(Q34085366)

English

Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

tumor progression

1 reference

based on heuristic

inferred from title

7

object named as

Derek LeRoith

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

object named as

Shoshana Yakar

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Makoto Anzo

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Laura J Cobb

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

David L Hwang

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Hemal Mehta

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Jonathan W Said

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pinchas Cohen

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

68

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

3342-3349

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Quantitative ontogeny of murine insulin-like growth factor (IGF)-I, IGF-binding protein-3 and the IGF-related acid-labile subunit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 July 2018

Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 July 2018

Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 July 2018

Co-expression of GH and GHR isoforms in prostate cancer cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 July 2018

Normal growth and development in the absence of hepatic insulin-like growth factor I

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 July 2018

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 July 2018

Prostate cancer in a transgenic mouse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 July 2018

Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 October 2018

Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 October 2018

Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 October 2018

A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 October 2018

Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 October 2018

Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 October 2018

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 October 2018

Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 October 2018

The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 October 2018

Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 October 2018

Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and Risk of Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928555

28 October 2018

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18451161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Null association between insulin-like growth factors, insulin-like growth factor-binding proteins, and prostate cancer in a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18451161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18451161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/18451161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth hormone and prostate cancer growth and metastasis in tumor-bearing animals

1 reference

https://pubmed.ncbi.nlm.nih.gov/18451161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18451161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era

1 reference

https://pubmed.ncbi.nlm.nih.gov/18451161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model

1 reference

https://pubmed.ncbi.nlm.nih.gov/18451161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18451161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/0008-5472.CAN-07-3165

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34085366&oldid=2070786149"